ELINA ZHUKOVA: Open Payments
NPI 1184368946 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 25 payments from 11 companies in 2025. Trend: 2023 $531 · 2024 $831 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 7 | $160 |
| Alexion Pharmaceuticals, Inc. | 4 | $118 |
| Biogen, Inc. | 3 | $66 |
| ABBVIE INC. | 2 | $65 |
| Octapharma USA, Inc. | 2 | $62 |
| PFIZER INC. | 2 | $50 |
| Ceribell, Inc. | 1 | $34 |
| Invivyd Inc | 1 | $30 |
| ARGENX US, INC. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: ULTOMIRIS, ELIQUIS, LEQEMBI, FIBRYGA, POCKET EEG DEVICE, UBRELVY, QULIPTA, PEMGARDA.
Industry payments across NY — which companies pay providers there.
